Analyst Ratings for Skye Bioscience (SKYE)
SKYE Rating Summary
SKYE Price Target Summary
- Highest: $20.00 (Piper Sandler)
- Lowest: $2.00 (Craig-Hallum)
- Average: $9.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$9.67 (+1242.6%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 76%
Avg. $ Target:
$9.67 (+1242.6%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 76%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/6/2025 | Craig-Hallum | Albert Lowe | Downgrade | Hold (Buy) |
2.00 (N/A) |
4.75 (0.72) |
-84.84% | Details |
| 10/6/2025 | Cantor Fitzgerald » Updated 1/15/2026 |
Kristen Kluska | Downgrade | Neutral (Overweight) |
2.00 (N/A) |
4.75 (0.72) |
-84.84% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
